<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>XRCC2 and XRCC3 proteins are structurally and functionally related to RAD51 which play an important role in the homologous recombination, the process frequently involved in <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> transformation </plain></SENT>
<SENT sid="1" pm="."><plain>In our previous work we show that the 135G&gt;C polymorphism (rs1801320) of the RAD51 gene can modify the effect of the Thr241Met polymorphism (rs861539) of the XRCC3 gene </plain></SENT>
<SENT sid="2" pm="."><plain>We tested the association between the 135G&gt;C polymorphism of the RAD51 gene, the Thr241Met polymorphism of the XRCC3 gene and the Arg188His polymorphism (rs3218536) of the XRCC2 gene and <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> risk and clinicopathological parameters </plain></SENT>
<SENT sid="3" pm="."><plain>Polymorphisms were evaluated by restriction fragment length polymorphism polymerase chain reaction (RFLP-PCR) in 100 patients with invasive <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> of the colon and in 100 sex, age and ethnicity matched <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>-free controls </plain></SENT>
<SENT sid="4" pm="."><plain>We stratified the patients by genotypes, <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> Duke's and TNM stage and calculated the linkage of each genotype with each stratum </plain></SENT>
<SENT sid="5" pm="."><plain>Carriers of Arg188Arg/Me241tMet, His188His/Thr241Thr and His188His/G135G genotypes had an increased risk of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> occurrence (OR 5.70, 95% CI 1.10-29.5; OR 12.4, 95% CI 1.63-94.9; OR 5.88, 95% CI 1.21-28.5, respectively) </plain></SENT>
<SENT sid="6" pm="."><plain>The C135C genotype decreased the risk of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> singly (OR 0.06, 95% CI 0.02-0.22) as well as in combination with other two polymorphisms </plain></SENT>
<SENT sid="7" pm="."><plain>TNM and Duke's staging were not related to any of these polymorphisms </plain></SENT>
<SENT sid="8" pm="."><plain>Our results suggest that the 135G&gt;C polymorphism of the RAD51 gene can be an independent marker of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> risk </plain></SENT>
<SENT sid="9" pm="."><plain>The Thr241Met polymorphism of the XRCC3 gene and the Arg188His polymorphism of the XRCC2 gene can modify the risk of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
</text></document>